Kineret® authorised for emergency use by FDA for the treatment of COVID-19 related pneumonia

/PRNewswire/ -- Sobi® today announced that the US Food and Drug Administration has granted Emergency Use Authorisation (EUA) for the use of Kineret® (anakinra)...

Related Keywords

Italy ,United States ,Stockholm ,Sweden ,Greece ,America ,Anders Ullman ,Evangelosj Giamarellos Bourboulis ,Assistance Center ,Linkedin ,World Health Organization ,Drug Administration ,Sobi Investor Relations Team ,Information Exchange ,Youtube ,Hellenic Institute For The Study Of Sepsis ,Head Of Research Development ,Emergency Use Authorisation ,Chief Medical Officer ,Nature Medicine ,Guided Anakinra Treatment ,Severe Respiratory Failure ,Hellenic Institute ,Emergency Task Force ,Organ Failure Assessment ,Familial Mediterranean ,Systemic Juvenile Idiopathic Arthritis ,Adult Onset Still ,Cytokine Storm Is Vital ,Tissue Specific Inflammation ,Innate Immun ,North America ,Middle East ,Sobi Media ,Orphan Biovitrum ,Swedish Orphan Biovitrum Ab ,